Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Non-Current Assets (2016 - 2026)

Pharma-Bio Serv's Non-Current Assets history spans 16 years, with the latest figure at $224457.0 for Q1 2026.

  • For Q1 2026, Non-Current Assets fell 58.63% year-over-year to $224457.0; the TTM value through Jan 2026 reached $1.4 million, down 27.14%, while the annual FY2025 figure was $266201.0, 55.15% down from the prior year.
  • Non-Current Assets reached $224457.0 in Q1 2026 per PBSV's latest filing, down from $266201.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.7 million in Q1 2023 to a low of $224457.0 in Q1 2026.
  • Average Non-Current Assets over 5 years is $685533.2, with a median of $542611.0 recorded in 2025.
  • Peak YoY movement for Non-Current Assets: surged 153.05% in 2023, then tumbled 82.87% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $707243.0 in 2022, then decreased by 29.17% to $500964.0 in 2023, then grew by 18.47% to $593477.0 in 2024, then plummeted by 55.15% to $266201.0 in 2025, then fell by 15.68% to $224457.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Non-Current Assets are $224457.0 (Q1 2026), $266201.0 (Q4 2025), and $429922.0 (Q3 2025).